“ Just like chemotherapy agents belonging to taxane groups, fenbendazole powder can sensitize tumors to radiotherapy. Fenbendazole was found effective against not only regular types of NSCLC (non-small cell lung cancer) but also against a very common disease in humans (30% of all NSCLC cases) which, is very aggressive and hardly accessible with chemotherapy KRAS-mutant cancer.”